Back to Oncology
Oncologyv2017Evidence-Based

iRECIST Response (Immunotherapy)

Simplified iRECIST response classification for solid tumors on immunotherapy.

Clinical Input Parameters

%
Range: -100 — 300 %
Clinical Assessment
Awaiting Parameters
irecist
—category
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The iRECIST Response (Immunotherapy) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

iCR: all gone. iPR: >=30% decrease. iUPD: >=20% increase (+5mm absolute) or new lesions. Confirmation required for iCPD.

Clinical Pearls & Practice Notes

  • Simplified bedside version; full iRECIST includes confirmatory assessment and new-lesion measurement rules.

Evidence & Literature Citations

  1. Seymour L, Bogaerts J, Perrone A, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017;18(3):e143-e152.

Score Interpretation Ranges

iCR0 – 0 pts

Complete response

iPR1 – 1 pts

Partial response

iSD2 – 2 pts

Stable disease

iUPD3 – 3 pts

Unconfirmed progression

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.